Akebia Therapeutics (AKBA) Net Equity Issued and Repurchased (2013 - 2016)
Akebia Therapeutics (AKBA) posted quarterly Net Equity Issued and Repurchased of $2.2 million for Q3 2016, down 84.51% year-over-year from $14.2 million in Q4 2015, and down 84.51% quarter-over-quarter from $14.2 million in Q3 2015.
Akebia Therapeutics (AKBA) Net Equity Issued and Repurchased (2013 - 2016) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $2.2 million the latest figure, recorded in Q3 2016.
- In Q3 2016, Net Equity Issued and Repurchased fell 84.51% year-over-year to $2.2 million; the TTM figure through Sep 2016 stood at $16.5 million (up 355.0% YoY), while the FY2017 annual figure was $373.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to $2.2 million in Q3 2016 per AKBA's latest filing, from $14.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $105.8 million in Q1 2014 and bottomed at -$10.7 million in Q3 2014.
- Historically, Net Equity Issued and Repurchased has averaged $14.8 million across 4 years, with a median of $1.1 million in 2015.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 233.18% in 2015 and fell as far as 99.95% in 2015.
- Akebia Therapeutics' Net Equity Issued and Repurchased stood at -$2.5 million in 2013, then surged by 101.4% to $35000.0 in 2014, then jumped by 40471.43% to $14.2 million in 2015, then plunged by 84.51% to $2.2 million in 2016.
- Business Quant data shows AKBA's Net Equity Issued and Repurchased at $2.2 million in Q3 2016, $14.2 million in Q3 2015, and $50000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 2.20 Mn |
| Sep 30, 2016 | 2.20 Mn |
| Sep 30, 2015 | 14.20 Mn |
| Sep 30, 2015 | 14.20 Mn |
| Mar 31, 2015 | 50,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Dec 31, 2014 | 35,000.00 |
| Dec 31, 2014 | 35,000.00 |
| Sep 30, 2014 | -10.66 Mn |
| Sep 30, 2014 | -10.66 Mn |
| Jun 30, 2014 | 9.20 Mn |
| Jun 30, 2014 | 9.20 Mn |
| Mar 31, 2014 | 105.75 Mn |
| Mar 31, 2014 | 105.75 Mn |
| Dec 31, 2013 | -2.50 Mn |
| Dec 31, 2013 | -2.50 Mn |